References
- Poser S. Oral contraceptives—indications and neurological complications. Fortschr Neurol Psychiatr Grenzgeb 1977; 45: 412–419
- Jandolo B, Casaglia P, Morace E. Cerebral pseudotumor and oral contraceptives. Riv Neurobiol 1978; 24: 106–108
- Canon S H. Optometric implications of systemic drug therapy. J Am Optom Assoc 1985; 56: 843–844
- Ireland B, Corbett J J, Wallace R B. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47: 315–320
- Danze F, Rosa A, Mizon J P. Benign intracranial hypertension (pseudotumor cerebri). 12 cases. Rev Neurol (Paris) 1984; 140: 37–44
- Hannerz J, Greitz D, Ericson K. Is there a relationship between obesity and intracranial hypertension?. Int J Obes Relat Metab Disord 1995; 19: 240–244
- Giuseffi V, Wall M, Siegel P Z, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41: 239–244
- Singh K, Chye G C. Adverse effects associated with contraceptive implants: incidence, prevention and management. Adv Contracept 1998; 14: 1–13
- Glueck C J, Aregawi D, Goldenberg N, et al. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med 2005; 145: 72–82
- Malek N, Lebuisson D A. Adverse ocular reactions to oral contraceptive use. Contracept Fertil Sex (Paris) 1992; 20: 441–444